Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Carson

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Journal of the American College of Cardiology|December 20, 2005
Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trialPeter Carson, Inder Anand, Christopher O'Connor, et al.
Circulation|December 13, 2006
Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) TrialLeslie A Saxon, Michael R Bristow, John Boehmer, et al.
The American Journal of Cardiology|September 6, 2011
Mode of death and hospitalization from the Second Follow-up Serial Infusions of Nesiritide (FUSION II) trial and comparison of clinical events committee adjudicated versus investigator reported outcomesChristopher M O'Connor, Mona Fiuzat, Joann Lindenfeld, et al.
American Heart Journal|October 12, 2010
Determination of hospitalization type by investigator case report form or adjudication committee in a large heart failure clinical trial (β-Blocker Evaluation of Survival Trial [BEST])Peter Carson, Mona Fiuzat, Christopher O'Connor, et al.
Journal of Cardiac Failure|November 13, 2007
Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failureJalal K Ghali, John Boehmer, Arthur M Feldman, et al.
JACC. Heart Failure|March 14, 2014
The STICH trial (Surgical Treatment for Ischemic Heart Failure): mode-of-death resultsPeter Carson, John Wertheimer, Alan Miller, et al.
The New England Journal of Medicine|May 21, 2004
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failureMichael R Bristow, Leslie A Saxon, John Boehmer, et al.
Circulation|March 21, 2007
Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure TrialAnne L Taylor, Susan Ziesche, Clyde W Yancy, et al.
Circulation|December 28, 2006
Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failureJoAnn Lindenfeld, Arthur M Feldman, Leslie Saxon, et al.
Journal of the American College of Cardiology|December 20, 2005
Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trialArthur M Feldman, Gregory de Lissovoy, Michael R Bristow, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Journal of the American College of Cardiology|December 20, 2005
Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trialPeter Carson, Inder Anand, Christopher O'Connor, et al.
Circulation|December 13, 2006
Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) TrialLeslie A Saxon, Michael R Bristow, John Boehmer, et al.
The American Journal of Cardiology|September 6, 2011
Mode of death and hospitalization from the Second Follow-up Serial Infusions of Nesiritide (FUSION II) trial and comparison of clinical events committee adjudicated versus investigator reported outcomesChristopher M O'Connor, Mona Fiuzat, Joann Lindenfeld, et al.
American Heart Journal|October 12, 2010
Determination of hospitalization type by investigator case report form or adjudication committee in a large heart failure clinical trial (β-Blocker Evaluation of Survival Trial [BEST])Peter Carson, Mona Fiuzat, Christopher O'Connor, et al.
Journal of Cardiac Failure|November 13, 2007
Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failureJalal K Ghali, John Boehmer, Arthur M Feldman, et al.
JACC. Heart Failure|March 14, 2014
The STICH trial (Surgical Treatment for Ischemic Heart Failure): mode-of-death resultsPeter Carson, John Wertheimer, Alan Miller, et al.
The New England Journal of Medicine|May 21, 2004
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failureMichael R Bristow, Leslie A Saxon, John Boehmer, et al.
Circulation|March 21, 2007
Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure TrialAnne L Taylor, Susan Ziesche, Clyde W Yancy, et al.
Circulation|December 28, 2006
Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failureJoAnn Lindenfeld, Arthur M Feldman, Leslie Saxon, et al.
Journal of the American College of Cardiology|December 20, 2005
Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trialArthur M Feldman, Gregory de Lissovoy, Michael R Bristow, et al.
Pageof 5